Publications by authors named "Luke Mercer"

Claim this Profile
R
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
Thomas R Lane, Julie Dyall, Luke Mercer, Caleb Goodin, Daniel H Foil

Antiviral Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT).
Tsutomu Akama, Yong-Kang Zhang, Yvonne R Freund, Pamela Berry, Joanne Lee, Luke Mercer

Bioorg Med Chem Lett· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
Wesley C Van Voorhis, John H Adams, Roberto Adelfio, Vida Ahyong, Myles H Akabas, Luke Mercer

PLoS Pathog· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis.
Stephen Wring, Eric Gaukel, Bakela Nare, Robert Jacobs, Beth Beaudet, Luke Mercer

Parasitology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis.
Tana Bowling, Luke Mercer, Robert Don, Robert Jacobs, Bakela Nare

Int J Parasitol Drugs Drug Resist· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.
Robert T Jacobs, Bakela Nare, Stephen A Wring, Matthew D Orr, Daitao Chen, Luke T Mercer

PLoS Negl Trop Dis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei.
Joe B Perales, Jennifer Freeman, Cyrus J Bacchi, Tana Bowling, Robert Don, Luke Mercer

Bioorg Med Chem Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach.
Luke Mercer, Tana Bowling, Joe Perales, Jennifer Freeman, Tien Nguyen

PLoS Negl Trop Dis· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.
Bakela Nare, Stephen Wring, Cyrus Bacchi, Beth Beaudet, Tana Bowling, Luke Mercer

Antimicrob Agents Chemother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis